NCT00375076View on ClinicalTrials.gov

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 2006

Study Completion Date

May 31, 2008

Conditions

Cancer

Interventions

DRUG

enoxaparin

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT00375076 - Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients | Biotech Hunter | Biotech Hunter